Emergent BioSolutions Inc. - COM (EBS)

Historical Portfolio Holders from Q1 2014 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / COM
Shares, excl. options Q3 2024
31.7M
Holdings value Q3 2024
$265M
Value change Q3 2024
+$30.9M
Grand Portfolio weight change Q3 2024
+0%
Number of holders
137
Number of buys Q3 2024
60
Number of sells Q3 2024
-79
Average buys Q3 2024 %
+0%
Average sells Q3 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 31.7M $265M +$30.9M $8.35 138
2024 Q2 30.4M $208M -$26.6M $6.82 138
2024 Q1 35.9M $90.8M -$12.1M $2.53 117
2023 Q4 40.9M $98.1M -$3.03M $2.40 129
2023 Q3 41.3M $141M -$26.3M $3.40 158
2023 Q2 45.7M $336M +$1.39M $7.35 176
2023 Q1 44.9M $465M -$16.9M $10.36 186
2022 Q4 46.2M $546M +$42.5M $11.81 191
2022 Q3 40.6M $852M -$48.7M $20.99 192
2022 Q2 41.2M $1.28B -$19.2M $31.04 217
2022 Q1 41.7M $1.71B -$22.8M $41.06 233
2021 Q4 42.5M $1.85B -$107M $43.47 241
2021 Q3 44.5M $2.23B -$19.7M $50.07 269
2021 Q2 44.7M $2.82B -$43.7M $62.99 284
2021 Q1 44.5M $4.12B +$64.7M $92.91 334
2020 Q4 44.3M $3.97B +$94M $89.60 349
2020 Q3 42.9M $4.43B -$190M $103.33 354
2020 Q2 53.5M $4.19B +$625M $79.08 294
2020 Q1 44.9M $2.6B +$7.89M $57.86 257
2019 Q4 44.6M $2.41B -$6.08M $53.95 232
2019 Q3 44.7M $2.34B -$21.9M $52.28 241
2019 Q2 45.5M $2.2B +$64.4M $48.31 229
2019 Q1 44.8M $2.27B +$80.9M $50.52 266
2018 Q4 43.1M $2.55B +$34.1M $59.28 295
2018 Q3 42.4M $2.79B +$15.5M $65.83 270
2018 Q2 42.6M $2.15B +$23.9M $50.49 257
2018 Q1 42.1M $2.21B +$57M $52.65 270
2017 Q4 40.4M $1.88B +$152M $46.47 234
2017 Q3 37.1M $1.5B +$62.1M $40.45 197
2017 Q2 35.6M $1.2B +$6.64M $33.91 181
2017 Q1 35.6M $1.03B +$95M $29.04 174
2016 Q4 35M $1.15B -$16.4M $32.84 203
2016 Q3 35.9M $1.13B -$1.13M $31.53 199
2016 Q2 35.5M $999M +$86.6M $28.12 216
2016 Q1 33.6M $1.22B +$24.2M $36.35 209
2015 Q4 32.8M $1.31B +$25.9M $40.01 202
2015 Q3 32.1M $916M +$35.7M $28.49 191
2015 Q2 31M $1.02B +$26.7M $32.95 181
2015 Q1 30.3M $873M +$37.7M $28.76 167
2014 Q4 29.1M $792M -$901K $27.23 163
2014 Q3 28.8M $615M -$2.15K $21.31 159
2014 Q2 28.7M $645M -$647K $22.46 156
2014 Q1 28.6M $722M +$91.2M $25.27 162